{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T21:55:10Z","timestamp":1783979710232,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Open Foundation of the National Virus Resource Center","award":["NVRC-PY-01"],"award-info":[{"award-number":["NVRC-PY-01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Influenza A virus remains a persistent threat, continuously evolving and contributing to seasonal epidemics and potential pandemics. In this study, we analyzed clinical samples collected from pediatric patients in Shanghai between 2022 and 2023, following the SARS-CoV-2 pandemic, to assess the genetic diversity of circulating influenza A virus strains. Out of 88 clinical samples that were positive for influenza A virus, seven isolates were successfully cultured and subjected to whole-genome sequencing. Whole-genome sequencing was performed using the Illumina high-throughput sequencing platform, while missing genomic segments, which were identified in the whole-genome sequence of isolates, were later amplified via standard PCR and Sanger sequencing. Phylogenetic analysis revealed a significant divergence between H3N2 strains from 2023 to those from 2022, suggesting a potential decline in vaccine efficacy over successive seasons. A H1N1 strain isolated from 2022 exhibited close genetic similarity to the vaccine strain. Mutational analysis identified key substitutions in the hemagglutinin and neuraminidase regions, including the I222V mutation in the neuraminidase segment of sample B623080303, which is associated with strong resistance to oseltamivir and peramivir. Another highly drug-resistant N206D mutation in the hemagglutinin region, detected in four clinical isolates, was found to alter host specificity by reducing binding affinity to human-like \u03b12,6-linked receptors while increasing affinity for avian-like \u03b12,3-linked receptors, thereby influencing host adaptation dynamics. The findings provide critical insights into the evolutionary trends of influenza A virus strains post-COVID-19 pandemic and their potential implications for vaccine effectiveness and antiviral resistance.<\/jats:p>","DOI":"10.1186\/s12985-025-03060-7","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T13:36:30Z","timestamp":1770212190000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Isolation, identification, and whole genome sequencing analysis of influenza A virus clinical isolates from Shanghai, China, during 2022\u20132023"],"prefix":"10.1186","volume":"23","author":[{"given":"Muhammad Asif","family":"Raza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Awais","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihuan","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Nabeel","family":"Amjad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghayyas Ud","family":"Din","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahsan Ali","family":"Bhutto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingdie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aguang","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huajie","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"issue":"5","key":"3060_CR1","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3390\/v14051036","volume":"14","author":"RM Skelton","year":"2022","unstructured":"Skelton RM, Huber VC. Comparing influenza virus biology for understanding influenza D virus. Viruses. 2022;14(5):1036.","journal-title":"Viruses"},{"key":"3060_CR2","doi-asserted-by":"publisher","first-page":"1435384","DOI":"10.3389\/fmicb.2024.1435384","volume":"15","author":"MA Raza","year":"2025","unstructured":"Raza MA, Ashraf MA, Amjad MN, Din GU, Shen B, Hu Y. The peculiar characteristics and advancement in diagnostic methodologies of influenza A virus. Front Microbiol. 2025;15:1435384.","journal-title":"Front Microbiol"},{"key":"3060_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1467029","volume":"15","author":"MA Ashraf","year":"2024","unstructured":"Ashraf MA, Raza MA, Amjad MN, Ud Din G, Yue L, Shen B, et al. A comprehensive review of influenza B virus, its biological and clinical aspects. Front Microbiol. 2024;15:1467029.","journal-title":"Front Microbiol"},{"issue":"11","key":"3060_CR4","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.3390\/v16111728","volume":"16","author":"N Klivleyeva","year":"2024","unstructured":"Klivleyeva N, Saktaganov N, Glebova T, Lukmanova G, Ongarbayeva N, Webby R. Influenza A viruses in the swine population: ecology and geographical distribution. Viruses. 2024;16(11):1728.","journal-title":"Viruses"},{"key":"3060_CR5","doi-asserted-by":"crossref","unstructured":"Roberts NJ Jr, Krilov LR. The continued threat of influenza A viruses. MDPI; 2022. p. 883.","DOI":"10.3390\/v14050883"},{"key":"3060_CR6","unstructured":"Paukett MR. Revenue Impacts of the 2015 Avian Influenza Virus Outbreak on United States Table Egg Wholesalers 2016."},{"key":"3060_CR7","unstructured":"Haveri A, Influenza vaccine induced antibody. Responses in relation to evolution of influenza A viruses."},{"key":"3060_CR8","unstructured":"S\u00e1nchez de Prada L. Humoral immune response after seasonal influenza vaccination. 2023."},{"key":"3060_CR9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/978-1-0716-0346-8_20","volume-title":"Animal influenza virus: methods and protocols","author":"J Zhang","year":"2020","unstructured":"Zhang J, Gauger PC. Isolation of swine influenza A virus in cell cultures and embryonated chicken eggs. In: Animal influenza virus: methods and protocols. Springer US; 2020. p. 281\u201394."},{"key":"3060_CR10","unstructured":"Bissinger T. Evaluation of MDCK suspension cell lines for influenza A virus production: media, metabolism, and process conditions 2020."},{"issue":"1","key":"3060_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2022.101151","volume":"3","author":"I-E Galani","year":"2022","unstructured":"Galani I-E, Triantafyllia V, Eleminiadou E-E, Andreakos E. Protocol for influenza A virus infection of mice and viral load determination. STAR Protoc. 2022;3(1):101151.","journal-title":"STAR Protoc"},{"issue":"1","key":"3060_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.slasd.2023.10.008","volume":"29","author":"Y Martinez-Gzegozewska","year":"2024","unstructured":"Martinez-Gzegozewska Y, Rasmussen L, McKellip S, Manuvakhova A, Nebane NM, Reece AJ, et al. High-throughput cell-based immunofluorescence assays against influenza. SLAS Discov. 2024;29(1):66\u201376.","journal-title":"SLAS Discov"},{"issue":"5","key":"3060_CR13","doi-asserted-by":"publisher","first-page":"276","DOI":"10.18699\/VJ20.620","volume":"22","author":"I Petrova","year":"2020","unstructured":"Petrova I, Zaitsev B, Taranov O. Concentration of viruses and electron microscopy. Vavilov J Genet Breed. 2020;22(5):276.","journal-title":"Vavilov J Genet Breed"},{"issue":"67","key":"3060_CR14","doi-asserted-by":"publisher","DOI":"10.21105\/joss.03773","volume":"6","author":"I Aksamentov","year":"2021","unstructured":"Aksamentov I, Roemer C, Hodcroft EB, Neher RA. Nextclade: clade assignment, mutation calling and quality control for viral genomes. J Open Source Softw. 2021;6(67):3773.","journal-title":"J Open Source Softw"},{"issue":"1","key":"3060_CR15","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.virol.2010.01.036","volume":"401","author":"BW Leung","year":"2010","unstructured":"Leung BW, Chen H, Brownlee GG. Correlation between polymerase activity and pathogenicity in two Duck H5N1 influenza viruses suggests that the polymerase contributes to pathogenicity. Virology. 2010;401(1):96\u2013106.","journal-title":"Virology"},{"issue":"19","key":"3060_CR16","doi-asserted-by":"publisher","first-page":"10292","DOI":"10.1128\/JVI.00921-07","volume":"81","author":"B Finkelstein David","year":"2007","unstructured":"Finkelstein David B, Mukatira S, Mehta Perdeep K, Obenauer John C, Su X, Webster Robert G, et al. Persistent host markers in pandemic and H5N1 influenza viruses. J Virol. 2007;81(19):10292\u20139.","journal-title":"J Virol"},{"issue":"23","key":"3060_CR17","doi-asserted-by":"publisher","first-page":"12911","DOI":"10.1128\/JVI.01522-07","volume":"81","author":"NV Kaverin","year":"2007","unstructured":"Kaverin NV, Rudneva IA, Govorkova EA, Timofeeva TA, Shilov AA, Kochergin-Nikitsky KS, et al. Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies. J Virol. 2007;81(23):12911\u20137.","journal-title":"J Virol"},{"issue":"13","key":"3060_CR18","doi-asserted-by":"publisher","first-page":"6570","DOI":"10.1128\/JVI.00221-10","volume":"84","author":"W Wang","year":"2010","unstructured":"Wang W, Lu B, Zhou H, Suguitan AL Jr, Cheng X, Subbarao K, et al. Glycosylation at 158 N of the hemagglutinin protein and receptor binding specificity synergistically affect the antigenicity and immunogenicity of a live attenuated H5N1 A\/Vietnam\/1203\/2004 vaccine virus in ferrets. J Virol. 2010;84(13):6570\u20137.","journal-title":"J Virol"},{"issue":"1","key":"3060_CR19","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.virol.2011.10.006","volume":"422","author":"LM Chen","year":"2012","unstructured":"Chen LM, Blixt O, Stevens J, Lipatov AS, Davis CT, Collins BE, et al. In vitro evolution of H5N1 avian influenza virus toward human-type receptor specificity. Virology. 2012;422(1):105\u201313.","journal-title":"Virology"},{"issue":"1","key":"3060_CR20","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1128\/JVI.78.1.240-249.2004","volume":"78","author":"NV Kaverin","year":"2004","unstructured":"Kaverin NV, Rudneva IA, Ilyushina NA, Lipatov AS, Krauss S, Webster RG. Structural differences among hemagglutinins of influenza A virus subtypes are reflected in their antigenic architecture: analysis of H9 escape mutants. J Virol. 2004;78(1):240\u20139.","journal-title":"J Virol"},{"issue":"12","key":"3060_CR21","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1111\/j.1348-0421.2007.tb04013.x","volume":"51","author":"S Nakajima","year":"2007","unstructured":"Nakajima S, Nakajima K, Nobusawa E, Zhao J, Tanaka S, Fukuzawa K. Comparison of epitope structures of H3HAs through protein modeling of influenza A virus hemagglutinin: mechanism for selection of antigenic variants in the presence of a monoclonal antibody. Microbiol Immunol. 2007;51(12):1179\u201387.","journal-title":"Microbiol Immunol"},{"issue":"1","key":"3060_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.virol.2005.05.009","volume":"339","author":"U Gulati","year":"2005","unstructured":"Gulati U, Wu W, Gulati S, Kumari K, Waner JL, Air GM. Mismatched hemagglutinin and neuraminidase specificities in recent human H3N2 influenza viruses. Virology. 2005;339(1):12\u201320.","journal-title":"Virology"},{"key":"3060_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.antiviral.2015.02.003","volume":"117","author":"E Takashita","year":"2015","unstructured":"Takashita E, Meijer A, Lackenby A, Gubareva L, Rebelo-de-Andrade H, Besselaar T, et al. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013\u20132014. Antiviral Res. 2015;117:27\u201338.","journal-title":"Antiviral Res"},{"issue":"10","key":"3060_CR24","doi-asserted-by":"publisher","first-page":"001648","DOI":"10.1099\/jgv.0.001648","volume":"102","author":"S Hussain","year":"2021","unstructured":"Hussain S, Daniels RS, Wharton SA, Howell S, Halai C, Kunzelmann S et al. Reduced sialidase activity of influenza A(H3N2) neuraminidase associated with positively charged amino acid substitutions. J Gen Virol. 2021;102(10):001648.  https:\/\/doi.org\/10.1099\/jgv.0.001648.","journal-title":"J Gen Virol"},{"issue":"10","key":"3060_CR25","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.1128\/AAC.00334-09","volume":"53","author":"AC Hurt","year":"2009","unstructured":"Hurt AC, Holien JK, Barr IG. In vitro generation of neuraminidase inhibitor resistance in A(H5N1) influenza viruses. Antimicrob Agents Chemother. 2009;53(10):4433\u201340.","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"3060_CR26","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.3201\/eid1512.090845","volume":"15","author":"GW Chen","year":"2009","unstructured":"Chen GW, Shih SR. Genomic signatures of influenza A pandemic (H1N1) 2009 virus. Emerg Infect Dis. 2009;15(12):1897\u2013903.","journal-title":"Emerg Infect Dis"},{"key":"3060_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygeno.2024.110842","author":"E Espinosa","year":"2024","unstructured":"Espinosa E, Bautista R, Larrosa R, Plata O. Advancements in long-read genome sequencing technologies and algorithms. Genomics. 2024. https:\/\/doi.org\/10.1016\/j.ygeno.2024.110842.","journal-title":"Genomics"},{"issue":"11","key":"3060_CR28","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.humimm.2021.02.012","volume":"82","author":"T Hu","year":"2021","unstructured":"Hu T, Chitnis N, Monos D, Dinh A. Next-generation sequencing technologies: an overview. Hum Immunol. 2021;82(11):801\u201311.","journal-title":"Hum Immunol"},{"issue":"3","key":"3060_CR29","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/s41596-024-01065-0","volume":"20","author":"Y Kim","year":"2025","unstructured":"Kim Y, Cheng W, Cho C-S, Hwang Y, Si Y, Park A, et al. Seq-scope: repurposing illumina sequencing flow cells for high-resolution spatial transcriptomics. Nat Protoc. 2025;20(3):643\u201389.","journal-title":"Nat Protoc"},{"issue":"2","key":"3060_CR30","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1177\/10406387211068023","volume":"34","author":"RP Chauhan","year":"2022","unstructured":"Chauhan RP, Gordon ML. Review of genome sequencing technologies in molecular characterization of influenza A viruses in swine. J Vet Diagn Invest. 2022;34(2):177\u201389.","journal-title":"J Vet Diagn Invest"},{"key":"3060_CR31","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jcv.2016.03.005","volume":"79","author":"J McGinnis","year":"2016","unstructured":"McGinnis J, Laplante J, Shudt M, George KS. Next generation sequencing for whole genome analysis and surveillance of influenza A viruses. J Clin Virol. 2016;79:44\u201350.","journal-title":"J Clin Virol"},{"issue":"17","key":"3060_CR32","doi-asserted-by":"publisher","first-page":"e00626","DOI":"10.1128\/AEM.00626-21","volume":"87","author":"L Tedersoo","year":"2021","unstructured":"Tedersoo L, Albertsen M, Anslan S, Callahan B. Perspectives and benefits of high-throughput long-read sequencing in microbial ecology. Appl Environ Microbiol. 2021;87(17):e00626\u201321.","journal-title":"Appl Environ Microbiol"},{"key":"3060_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2022.127154","volume":"264","author":"I Akacin","year":"2022","unstructured":"Akacin I, Ersoy \u015e, Doluca O, G\u00fcng\u00f6rm\u00fc\u015fler M. Comparing the significance of the utilization of next generation and third generation sequencing technologies in microbial metagenomics. Microbiol Res. 2022;264:127154.","journal-title":"Microbiol Res"},{"issue":"12","key":"3060_CR34","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1007\/s00203-024-04181-3","volume":"206","author":"MA Raza","year":"2024","unstructured":"Raza MA, Ashraf MA. Drug resistance and possible therapeutic options against influenza A virus infection over past years. Arch Microbiol. 2024;206(12):458.","journal-title":"Arch Microbiol"},{"issue":"12","key":"3060_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad577","volume":"10","author":"A Fall","year":"2023","unstructured":"Fall A, Han L, Yunker M, Gong YN, Li TJ, Norton JM, et al. Evolution of influenza A(H3N2) viruses in 2 consecutive seasons of genomic surveillance, 2021\u20132023. Open Forum Infect Dis. 2023;10(12):ofad577.","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"3060_CR36","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.3201\/eid3007.240480","volume":"30","author":"MC Patel","year":"2024","unstructured":"Patel MC, Nguyen HT, Pascua PNQ, Gao R, Steel J, Kondor RJ, et al. Multicountry spread of influenza A(H1N1)pdm09 viruses with reduced oseltamivir Inhibition, May 2023-February 2024. Emerg Infect Dis. 2024;30(7):1410\u20135.","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"3060_CR37","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.chom.2017.05.011","volume":"21","author":"NC Wu","year":"2017","unstructured":"Wu NC, Xie J, Zheng T, Nycholat CM, Grande G, Paulson JC, et al. Diversity of functionally permissive sequences in the Receptor-Binding site of influenza hemagglutinin. Cell Host Microbe. 2017;21(6):742\u2013e538.","journal-title":"Cell Host Microbe"},{"key":"3060_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/v13071196","author":"YQS Soh","year":"2021","unstructured":"Soh YQS, Malone KD, Eguia RT, Bloom JD. Comprehensive profiling of mutations to influenza virus PB2 that confer resistance to the cap-binding inhibitor Pimodivir. Viruses. 2021. https:\/\/doi.org\/10.3390\/v13071196.","journal-title":"Viruses"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-03060-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-03060-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-03060-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:38:10Z","timestamp":1772793490000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12985-025-03060-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3060"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-03060-7","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"assertion":[{"value":"16 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committees of Shanghai Nanxiang Branch of Ruijin hospital, and complied with all relevant ethical regulations along with the written consent from the patients or their legal guardians. The handling of respiratory viruses was conducted in strict accordance with standard procedures for an advanced Biosafety Level 2 laboratory.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors are agreed to publish this research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"67"}}